We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Neurology

Journal Scan / Research · January 28, 2021

Fampridine and Acetazolamide in Episodic Ataxia Type 2 and Related Familial Episodic Ataxia

Neurology. Clinical practice

 

Additional Info

Disclosure statements are available on the authors' profiles:

Neurology. Clinical practice
Fampridine and Acetazolamide in EA2 and Related Familial EA: A Prospective Randomized Placebo-Controlled Trial
Neurol Clin Pract 2020 Dec 03;[EPub Ahead of Print], C Muth, J Teufel, L Schöls, et al

Further Reading